Detection of EML4-ALK fusion gene and features associated with EGFR mutations in Chinese patients with non-small-cell lung cancer

Eitemau Tebyg

• Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation
  gan: Wen, Miaomiao, et al.
  Cyhoeddwyd: (2018)
• Clinical Significance of EML4-ALK Fusion Gene and Association with EGFR and KRAS Gene Mutations in 208 Chinese Patients with Non-Small Cell Lung Cancer
  gan: Li, Ying, et al.
  Cyhoeddwyd: (2013)
• A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene
  gan: Tanaka, Hisashi, et al.
  Cyhoeddwyd: (2012)
• Research Progress in Non-small Cell Lung Cancer 
with Concomitant EML4-ALK Fusion Gene and EGFR Gene Mutation
  gan: Zhu ZENG, et al.
  Cyhoeddwyd: (2011-11-01)
• Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression
  gan: Zhang, Xuchao, et al.
  Cyhoeddwyd: (2010)